EICHOR

Recruiting studies: Elevated Cholesterol

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibi
Phase 2/Phase 3 · 1 location(s) · Beijing Suncadia Pharmaceuticals Co., Ltd · NCT07404553 CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
Phase 4 · 1 location(s) · West China Hospital · NCT07612774 PMMHRI-Pitavastatin Registry
Phase N/A · 1 location(s) · Polish Mother Memorial Hospital Research Institute · NCT06858982 Alirocumab in Patients on a Stable Dialysis Regimen
Phase 3 · 1 location(s) · Baylor Research Institute · NCT03480568 IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Phase 3 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07473960 Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Phase 3 · 1 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT05621070 Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia
NA · 1 location(s) · Institut Pasteur de Lille · NCT06894251 FELLAShip to Better Health
NA · 1 location(s) · University of Alabama at Birmingham · NCT07220213 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemi
Phase 2 · 34 location(s) · Regeneron Pharmaceuticals · NCT07477704 A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Phase 1 · 27 location(s) · Verve Therapeutics, Inc. · NCT06164730 Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT02009345 Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid an
Phase N/A · 1 location(s) · Elsan · NCT07252830 Multicomponent Intervention Study- Blood Donors With High Cholesterol
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT05693701 A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and
Phase 2 · 29 location(s) · Novartis Pharmaceuticals · NCT07610278 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT04941599 A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07543731 Complete Lifestyle Medicine Intervention Program
Phase N/A · 1 location(s) · Northern Ontario School of Medicine · NCT06192251 Screening for Familial Hypercholesterolemia in Children
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06555120 A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473 Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders
Phase N/A · 2 location(s) · The Miriam Hospital · NCT06747000 Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Cor
Phase N/A · 13 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT07447648 Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
EARLY_Phase 1 · 1 location(s) · RenJi Hospital · NCT06458010 Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
Phase N/A · 27 location(s) · Federico II University · NCT05430828 Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NA · 22 location(s) · Stephen Nicholls · NCT05325034 A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familia
Phase 2/Phase 3 · 38 location(s) · Merck Sharp & Dohme LLC · NCT07058077 Study To Evaluate The Efficacy And Safety Of A Nutritional Supplement Based On Bergamot, Artichoke And Other Ingredients
NA · 7 location(s) · Laboratoires Arkopharma · NCT07178769 The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Phase N/A · 1 location(s) · The Rogosin Institute · NCT01109368 National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un
Phase N/A · 27 location(s) · Hospital do Coracao · NCT06546137 "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"
NA · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07427472 Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-7
Phase 4 · 1 location(s) · Yonsei University · NCT03770312

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →